GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (HAM:2M6) » Definitions » YoY EBITDA Growth

Medtronic (HAM:2M6) YoY EBITDA Growth : 2.91% (As of Jan. 2024)


View and export this data going back to 1980. Start your Free Trial

What is Medtronic YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Medtronic's YoY EBITDA Growth for the quarter that ended in Jan. 2024 was 2.91%.

Medtronic's EBITDA per Share for the three months ended in Jan. 2024 was €1.59.


Medtronic YoY EBITDA Growth Historical Data

The historical data trend for Medtronic's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic YoY EBITDA Growth Chart

Medtronic Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.14 -12.78 -12.67 29.50 -1.05

Medtronic Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.46 -1.31 -1.16 -7.51 2.91

Medtronic YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Medtronic's YoY EBITDA Growth for the fiscal year that ended in Apr. 2023 is calculated as:

YoY EBITDA Growth (A: Apr. 2023 )
=(EBITDA per Share (A: Apr. 2023 )-EBITDA per Share (A: Apr. 2022 ))/ | EBITDA per Share (A: Apr. 2022 ) |
=(5.951-6.014)/ | 6.014 |
=-1.05 %

Medtronic's YoY EBITDA Growth for the quarter that ended in Jan. 2024 is calculated as:

YoY EBITDA Growth (Q: Jan. 2024 )
=(EBITDA per Share (Q: Jan. 2024 )-EBITDA per Share (Q: Jan. 2023 )) / | EBITDA per Share (Q: Jan. 2023 )) |
=(1.592-1.547)/ | 1.547 |
=2.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medtronic YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Medtronic's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Medtronic (HAM:2M6) Business Description

Address
Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Medtronic (HAM:2M6) Headlines

No Headlines